FDA breakthrough therapy designation of oncology products: The first-year experience.
Yangmin M. Ning
No relevant relationships to disclose
Tamy Kim
No relevant relationships to disclose
Virginia Ellen Maher
No relevant relationships to disclose
Amna Ibrahim
No relevant relationships to disclose
Anthony J. Murgo
No relevant relationships to disclose
Ann T. Farrell
No relevant relationships to disclose
Patricia Keegan
No relevant relationships to disclose
Robert L. Justice
No relevant relationships to disclose
Richard Pazdur
No relevant relationships to disclose